Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc TBQBF


Primary Symbol: EMHTF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Emerald Health Therapeutics Inc > EMH Q1 results - Demonstrates Continued Growth in Sales
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(9)
•••
Comment by goal111on May 31, 2019 12:13pm
99 Views
Post# 29788955

RE:RE:EMH Q1 results - Demonstrates Continued Growth in Sales

RE:RE:EMH Q1 results - Demonstrates Continued Growth in Sales
i believe upcoming quarters will have very strong numbers and will boost the momentum of share price. They are just starting to fill their po for Quebec, Alberta, Manitoba and PEI. SYNC 25 CBD oil will be a hit in the adult market and going generate alot of rev for the company. Lets hope soon they launch new product line with Natural Factors group and also bring Endo products in the Canadian retail market. Gl
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities